Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-11
DOI
10.1038/s41569-020-00493-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using Mendelian Randomization to Improve the Design of Randomized Trials
- (2021) Brian A. Ference et al. Cold Spring Harbor Perspectives in Medicine
- Alcohol Industry Involvement in the Moderate Alcohol and Cardiovascular Health Trial
- (2020) Gemma Mitchell et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
- (2020) Minna K. Karjalainen et al. ATHEROSCLEROSIS
- Using human genetics to guide the repurposing of medicines
- (2020) Jonas Bovijn et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- FDA Approval and Regulation of Pharmaceuticals, 1983-2018
- (2020) Jonathan J. Darrow et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer
- (2020) James Yarmolinsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
- (2020) Olivier J. Wouters et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Magic of Randomization versus the Myth of Real-World Evidence
- (2020) Rory Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease
- (2020) Connor A. Emdin et al. Circulation-Genomic and Precision Medicine
- Characterizing the Causal Pathway for Genetic Variants Associated with Neurological Phenotypes Using Human Brain-Derived Proteome Data
- (2020) Nelson K. Kibinge et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Mendel’s laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues
- (2020) George Davey Smith et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study
- (2020) Tom G Richardson et al. BMJ-British Medical Journal
- A powerful and versatile colocalization test
- (2020) Yangqing Deng et al. PLoS Computational Biology
- Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
- (2020) Tom G. Richardson et al. PLOS MEDICINE
- Polygenic modelling of treatment effect heterogeneity
- (2020) Zhi Ming Xu et al. GENETIC EPIDEMIOLOGY
- Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
- (2020) Jonas Bovijn et al. Science Translational Medicine
- Genetic drug target validation using Mendelian randomisation
- (2020) Amand F. Schmidt et al. Nature Communications
- Avoiding dynastic, assortative mating, and population stratification biases in Mendelian randomization through within-family analyses
- (2020) Ben Brumpton et al. Nature Communications
- Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy
- (2020) Tjerk S.J. Opstal et al. CIRCULATION
- Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
- (2020) Jie Zheng et al. NATURE GENETICS
- Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis
- (2020) Qin Wang et al. EUROPEAN HEART JOURNAL
- Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases
- (2020) Yuanjie Pang et al. JAMA Cardiology
- Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
- (2019) Eeva Sliz et al. CIRCULATION
- Apparent latent structure within the UK Biobank sample has implications for epidemiological analysis
- (2019) Simon Haworth et al. Nature Communications
- Human Genetics and Drug Development
- (2019) Michael V. Holmes NEW ENGLAND JOURNAL OF MEDICINE
- What is ‘LDL cholesterol’?
- (2019) Michael V. Holmes et al. Nature Reviews Cardiology
- Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events
- (2019) Jane Armitage et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can Mendelian Randomization Shift into Reverse Gear?
- (2019) Michael V. Holmes et al. CLINICAL CHEMISTRY
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China
- (2019) Iona Y Millwood et al. LANCET
- Trends in clinical success rates and therapeutic focus
- (2019) Helen Dowden et al. NATURE REVIEWS DRUG DISCOVERY
- Understanding the consequences of education inequality on cardiovascular disease: mendelian randomisation study
- (2019) Alice R Carter et al. BMJ-British Medical Journal
- Variability in aspirin efficacy: all in the genes?
- (2019) Colin Baigent et al. EUROPEAN HEART JOURNAL
- Commentary: Mendelian randomization and women’s health
- (2019) Jenny C Censin et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits
- (2019) Eleonora Porcu et al. Nature Communications
- Using Genetic Instruments to Estimate Interactions in Mendelian Randomization Studies
- (2019) Teri-Louise North et al. EPIDEMIOLOGY
- Genetic instrumental variable analysis: time to call mendelian randomization what it is. The example of alcohol and cardiovascular disease
- (2019) Kenneth J. Mukamal et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Within family Mendelian randomization studies
- (2019) Neil M Davies et al. HUMAN MOLECULAR GENETICS
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Causal relationships between obesity and the leading causes of death in women and men
- (2019) Jenny C. Censin et al. PLoS Genetics
- Improving the odds of drug development success through human genomics: modelling study
- (2019) Aroon D. Hingorani et al. Scientific Reports
- Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition
- (2019) Johannes Kettunen et al. PLOS BIOLOGY
- Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study
- (2019) Michael Wainberg et al. PLOS MEDICINE
- Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment Options
- (2018) Brian A Ference CLINICAL PHARMACOLOGY & THERAPEUTICS
- Understanding and misunderstanding randomized controlled trials
- (2018) Angus Deaton et al. SOCIAL SCIENCE & MEDICINE
- Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank
- (2018) Robert Carreras-Torres et al. BMJ-British Medical Journal
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- Role of obesity in smoking behaviour: Mendelian randomisation study in UK Biobank
- (2018) Robert Carreras-Torres et al. BMJ-British Medical Journal
- Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
- (2018) Neil M Davies et al. BMJ-British Medical Journal
- The MR-Base platform supports systematic causal inference across the human phenome
- (2018) Gibran Hemani et al. eLife
- Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm
- (2018) Seamus C. Harrison et al. JAMA Cardiology
- Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults
- (2018) Iona Y. Millwood et al. JAMA Cardiology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- Genomic atlas of the human plasma proteome
- (2018) Benjamin B. Sun et al. NATURE
- Apolipoprotein A-I Infusion Therapies for Coronary Disease
- (2018) Daniel J. Rader JAMA Cardiology
- An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings
- (2018) Eleanor Sanderson et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
- (2018) Sara B. Seidelmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Be open about drug failures to speed up research
- (2018) Enrica Alteri et al. NATURE
- Statistical pitfalls of personalized medicine
- (2018) Stephen Senn NATURE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- GWAS identifies 14 loci for device-measured physical activity and sleep duration
- (2018) Aiden Doherty et al. Nature Communications
- Nature as a Trialist?
- (2017) Sonja A. Swanson et al. EPIDEMIOLOGY
- How to use Mendelian randomization to anticipate the results of randomized trials
- (2017) Brian A Ference EUROPEAN HEART JOURNAL
- 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
- (2017) Ulf Landmesser et al. EUROPEAN HEART JOURNAL
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease
- (2017) Connor A. Emdin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic effects on gene expression across human tissues
- (2017) François Aguet et al. NATURE
- Dyslipidaemia: Revealing the effect of CETP inhibition in cardiovascular disease
- (2017) Michael V. Holmes et al. Nature Reviews Cardiology
- Mendelian randomization in cardiometabolic disease: challenges in evaluating causality
- (2017) Michael V. Holmes et al. Nature Reviews Cardiology
- Genetics of coronary artery disease: discovery, biology and clinical translation
- (2017) Amit V. Khera et al. NATURE REVIEWS GENETICS
- Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Education and coronary heart disease: mendelian randomisation study
- (2017) Taavi Tillmann et al. BMJ-British Medical Journal
- Genetic epidemiology and Mendelian randomization for informing disease therapeutics: Conceptual and methodological challenges
- (2017) Lavinia Paternoster et al. PLoS Genetics
- Education and coronary heart disease: mendelian randomisation study
- (2017) Taavi Tillmann et al. BMJ-British Medical Journal
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
- (2017) Amand F Schmidt et al. Lancet Diabetes & Endocrinology
- Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank
- (2017) Donald M. Lyall et al. JAMA Cardiology
- Evaluation of the Pleiotropic Effects of Statins
- (2017) Christopher Labos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations
- (2017) Anna-Maria Ordelheide et al. PLoS One
- Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies
- (2016) Philip C Haycock et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A phenome-wide association study of a lipoprotein-associated phospholipase A2loss-of-function variant in 90 000 Chinese adults
- (2016) Iona Y Millwood et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique
- (2016) Fernando Pires Hartwig et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein-Associated Phospholipase A 2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults
- (2016) Iona Y. Millwood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
- (2016) Peter Würtz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets
- (2016) Zhihong Zhu et al. NATURE GENETICS
- Phase II and phase III failures: 2013–2015
- (2016) Richard K. Harrison NATURE REVIEWS DRUG DISCOVERY
- Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
- (2016) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
- (2016) Robert A. Scott et al. Science Translational Medicine
- Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
- (2016) Johannes Kettunen et al. Nature Communications
- Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study
- (2016) Bram. P. Prins et al. PLOS MEDICINE
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes
- (2016) Jon White et al. JAMA Cardiology
- Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease
- (2015) Stephanie Ross et al. EUROPEAN HEART JOURNAL
- Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors
- (2015) Stephen Burgess et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia
- (2015) Peter J. Meikle et al. JOURNAL OF LIPID RESEARCH
- Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both
- (2015) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Drug Development
- (2015) Christopher B. Fordyce et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
- (2015) Lauren E. Mokry et al. PLOS MEDICINE
- Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis
- (2014) Michael V. Holmes et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mendelian randomization of blood lipids for coronary heart disease
- (2014) Michael V. Holmes et al. EUROPEAN HEART JOURNAL
- Mendelian randomization: genetic anchors for causal inference in epidemiological studies
- (2014) G. Davey Smith et al. HUMAN MOLECULAR GENETICS
- Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits
- (2014) Richard J Silverwood et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome
- (2014) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
- (2014) M. V. Holmes et al. BMJ-British Medical Journal
- Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics
- (2014) Claudia Giambartolomei et al. PLoS Genetics
- Metabolic Signatures of Adiposity in Young Adults: Mendelian Randomization Analysis and Effects of Weight Change
- (2014) Peter Würtz et al. PLOS MEDICINE
- Secretory Phospholipase A 2 -IIA and Cardiovascular Disease
- (2013) Michael V. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of Hemoglobin and Its Genes
- (2013) R. C. Hardison Cold Spring Harbor Perspectives in Medicine
- Liposuction Induces a Compensatory Increase of Visceral Fat Which Is Effectively Counteracted by Physical Activity: A Randomized Trial
- (2012) Fabiana Benatti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- LDL-Apheresis: Technical and Clinical Aspects
- (2012) Rolf Bambauer et al. TheScientificWorldJOURNAL
- Cigarette Smoking, Nicotine, and Body Weight
- (2011) J Audrain-McGovern et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Utility of genetic determinants of lipids and cardiovascular events in assessing risk
- (2011) Michael V. Holmes et al. Nature Reviews Cardiology
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
- (2010) Kiran Musunuru et al. NATURE
- What are biomarkers?
- (2010) Kyle Strimbu et al. Current Opinion in HIV and AIDS
- Separating the Mechanism-Based and Off-Target Actions of Cholesteryl Ester Transfer Protein Inhibitors With CETP Gene Polymorphisms
- (2009) Reecha Sofat et al. CIRCULATION
- Mendelian Randomization
- (2009) George Thanassoulis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomics and Cardiovascular Drug Development
- (2009) Andrew S. Plump et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk
- (2008) Alexander Thompson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phospholipase A2structure/function, mechanism, and signaling
- (2008) John E. Burke et al. JOURNAL OF LIPID RESEARCH
- Long-term Effects of Large-volume Liposuction on Metabolic Risk Factors for Coronary Heart Disease
- (2008) B. Selma Mohammed et al. Obesity
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
- (2007) Debbie A. Lawlor et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started